Evidence map›Paper›PMID 41204317›Full record

ArticleNeurological research and practice2025

CT perfusion identified potential treatment opportunities in one in five mild strokes.

Yohanna Kusuma, Bizhong Che, Presaad Pillai, Ximing Nie, Leonard Yeo Ll, Vijay K Sharma, Andrew Wong, Peter Riley, Benjamin Clissold, Paul Talman and 9 more

Abstract read
In one paragraph

Article in Neurological research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yohanna KusumaSchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia. dr_yohanna_kusuma@yahoo.com.sg.ORCID http://orcid.org/0000-0002-0946-3066
Bizhong CheThe First Affiliated Hospital of Xi'an Jiaotong University, International Obesity and Metabolic Disease Research Centre, Xi'an, Shaanxi, P. R. China.
Presaad PillaiDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Ximing NieDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Leonard Yeo LlYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Vijay K SharmaYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Andrew WongDepartment of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Peter RileySchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia.
Benjamin ClissoldSchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia.
Paul TalmanSchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia.
Mursyid BustamiDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Lyna SoertidewiDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
M Arief R KemalDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Indah A PutriDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Reza Aditya ArpandyDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Nandini Phalita LaksmiDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Nurul RakhmawatiDepartment of Neurology, National Brain Centre Prof Dr. dr Mahar Mardjono-Airlangga University, Jakarta/Surabaya, Indonesia.
Paul YielderSchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia.
Bernard YanDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia. bernard.yan@mh.org.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuidelines generally advise against reperfusion therapy in patients with mild stroke (NIHSS ≤ 5) and non-disabling symptoms. However, stroke severity can fluctuate, and clinical scores may not fully capture tissue at risk. Reliance on non-contrast CT (NCCT), potentially missing perfusion deficits or large vessel occlusions (LVOs). Advanced imaging-including CT angiography (CTA) and CT perfusion (CTP)-can reveal significant hypoperfusion in otherwise mild presentations. This study aimed to quantify the proportion of increased tissue-at-risk volumes (Tmax + 6s ≥ 15 mL) in patients with mild acute ischaemic stroke and identify associated factors and outcomes.

methodsWe included consecutive AIS patients within 24 h of onset from multicentre stroke registries in Australia and Indonesia. Only those with baseline NCCT, CTA, and CTP were analysed. Patients were stratified into NIHSS ≤ 5 and > 5. Tissue-at-risk was defined as Tmax + 6s ≥ 15 mL. Clinical, imaging, and outcome data were compared, and predictors of poor functional outcome (mRS 3-6 at 90-day) were assessed.

resultsOf 655 patients, 314 had NIHSS ≤ 5. Among these, 22.9% exhibited Tmax + 6s ≥ 15 mL, indicating significant hypoperfusion. This subgroup had worse 90-day outcomes (26.4% mRS 3-6 vs. 9.5%, p < 0.001). Tmax + 6s ≥ 15 mL, hypertension, and LVO were independently associated with poor outcome (adjusted ORs: 2.51, 3.15, and 2.74 respectively). ROC analysis demonstrated moderate discrimination of Tmax + 6s volume for poor functional outcome.

conclusionsA substantial proportion of mild stroke patients harbour treatable perfusion deficits. CT perfusion provides essential prognostic information beyond clinical severity, supporting its role in guiding therapeutic decisions-even in low NIHSS presentations where standard imaging may otherwise overlook tissue at risk.

Indexed as

Acute ischaemic strokeCT perfusionLarge vessel occlusionMild strokeReperfusion therapyTmax + 6s

Identifiers

PMID41204317
PMCPMC12595888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.